170 related articles for article (PubMed ID: 36682608)
1. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
Belabbas T; Yamada T; Egashira N; Hirota T; Suetsugu K; Mori Y; Kato K; Akashi K; Ieiri I
J Infect Chemother; 2023 Apr; 29(4):391-400. PubMed ID: 36682608
[TBL] [Abstract][Full Text] [Related]
2. Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin.
Hirai K; Ishii H; Shimoshikiryo T; Shimomura T; Tsuji D; Inoue K; Kadoiri T; Itoh K
Ther Drug Monit; 2016 Dec; 38(6):706-710. PubMed ID: 27681114
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics of Teicoplanin and Its Dosing Recommendations for Neutropenic Patients With Augmented Renal Clearance for Hematological Malignancies.
Sako KI; Nakamaru Y; Ikawa K; Maeda T; Goto S; Ishihara Y; Kato Y; Matsuda Y
Ther Drug Monit; 2021 Aug; 43(4):519-526. PubMed ID: 34250964
[TBL] [Abstract][Full Text] [Related]
5. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
[TBL] [Abstract][Full Text] [Related]
6. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
Ishigo T; Ibe Y; Fujii S; Kazuma S; Aigami T; Kashiwagi Y; Takada R; Takahashi S; Fukudo M; Toda T
J Infect Chemother; 2023 Aug; 29(8):769-777. PubMed ID: 37150254
[TBL] [Abstract][Full Text] [Related]
7. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
[TBL] [Abstract][Full Text] [Related]
8. Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance.
Hirai K; Ihara S; Kinae A; Ikegaya K; Suzuki M; Hirano K; Itoh K
Ther Drug Monit; 2016 Jun; 38(3):393-7. PubMed ID: 27172381
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance.
He CY; Ye PP; Liu B; Song L; van den Anker J; Zhao W
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0089721. PubMed ID: 34339268
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia.
He N; Dong F; Liu W; Zhai S
Infect Drug Resist; 2020; 13():1807-1821. PubMed ID: 32606830
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function.
Ishii H; Hirai K; Sugiyama K; Nakatani E; Kimura M; Itoh K
Ther Drug Monit; 2018 Dec; 40(6):693-698. PubMed ID: 30157096
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.
Fernández de Gatta Mdel M; Santos Buelga D; Sánchez Navarro A; Dominguez-Gil A; García MJ
Clin Pharmacokinet; 2009; 48(4):273-80. PubMed ID: 19492872
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y
J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878
[TBL] [Abstract][Full Text] [Related]
15. Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies.
Rao Q; Yang Y; Wang S; Zhu H; Jin L; Zhang J; Liu M
Int J Antimicrob Agents; 2023 Jul; 62(1):106841. PubMed ID: 37160241
[TBL] [Abstract][Full Text] [Related]
16. Clinical applicability of urinary creatinine clearance for determining the initial dose of vancomycin in critically ill patients.
Mikami R; Imai S; Hayakawa M; Sugawara M; Takekuma Y
J Infect Chemother; 2022 Feb; 28(2):199-205. PubMed ID: 34686459
[TBL] [Abstract][Full Text] [Related]
17. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of vancomycin in paediatric patients with febrile neutropenia and augmented renal clearance: development of new dosing recommendations.
Shimamoto Y; Verstegen RHJ; Mizuno T; Schechter T; Allen U; Ito S
J Antimicrob Chemother; 2021 Oct; 76(11):2932-2940. PubMed ID: 34480578
[TBL] [Abstract][Full Text] [Related]
19. A Regression Model to Predict Augmented Renal Clearance in Critically Ill Obstetric Patients and Effects on Vancomycin Treatment.
Tang L; Ding XY; Duan LF; Li L; Lu HD; Zhou F; Shi L; Lu J; Shen Y; Zhuang ZW; Sun JT; Zhou Q; Zhu CQ; Li JJ; Yu YX
Front Pharmacol; 2021; 12():622948. PubMed ID: 34177564
[No Abstract] [Full Text] [Related]
20. Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review.
Chung E; Sen J; Patel P; Seto W
Clin Pharmacokinet; 2021 Aug; 60(8):985-1001. PubMed ID: 34002357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]